https://www.selleckchem.com/products/wzb117.html
0038). After liraglutide treatment, cognitive scores were significantly correlated with changes in these activating brain regions (P less then 0.05), but no correlation was observed between the changes in cognitive function and changes of body mass index, blood pressure, and glycemic levels. Conclusions We concluded that liraglutide improves cognitive decline in patients with type 2 diabetes mellitus. This beneficial effect is independent of its hypoglycemic effect and weight loss. The optimal intervention should be targeted to cognitive